SpinDiag is a German health care startup founded in 2016 with the slogan "The infection control solution." The company is a spin-off of Hahn-Schickard, a renowned research institution for microsystems technology. SpinDiag is focused on developing an automated point-of-care system for the screening of respiratory pathogens using its patented microfluidic platform, LabDisk. This innovative platform enables broad, fast, and affordable screening for pathogens such as SARS-CoV-2 and drug-resistant pathogens.
Recently, SpinDiag secured a significant €15.00M debt financing investment from the European Investment Bank (EIB) on 17 October 2022. The company's headquarters is located in Freiburg, Germany.
SpinDiag's commitment to addressing critical healthcare challenges through cutting-edge technology and its recent substantial investment from a prominent institution positions it as a compelling player in the infectious diseases diagnostics market.